Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

6.890 -0.060 (-0.86%)
Streaming Delayed Price Updated: 1:41 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Angiodynamics Inc

< Previous 1 2 3 4 5 6 7 Next >
Here's Why This Hidden Growth Stock Is a Buy
This medical device company may not be a household name, but it could be an up-and-comer. 
Via The Motley Fool
$20 Million Bet On Rocket Pharmaceuticals? 3 Stocks Insiders Are Buying
Although US crude oil prices traded lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
Constellation Brands To Rally 21%? Plus Wells Fargo Predicts $225 For Visa
UBS raised Constellation Brands, Inc. (NYSE: STZ) price target from $270 to $281. Constellation shares fell 0.1% to $232.38 in pre-market trading. 
Via Benzinga
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers 
Via Benzinga
Why AngioDynamics Stock Just Crashed 12%
Is AngioDynamics' earnings miss a buying opportunity? 
Via The Motley Fool
AngioDynamics Shares Fall On Lower Than Expected Q1 Earnings, Reaffirms Annual Guidance
Via Benzinga
AngioDynamics: Q1 Earnings Insights
AngioDynamics (NASDAQ:ANGO) reported its Q1 earnings results on Thursday, October 6, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. 
Via Benzinga
Stocks Edge Lower As Bond Yields Rise
Wall Street is taking a step back, as sentiment wanes and bond yields rise. 
Via Talk Markets
Raymond James Cuts Price Target On AngioDynamics
Via Benzinga
AngioDynamics' Q4 Top-Line Beats Street View, Issues Mixed FY23 Guidance
Via Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of... 
Via Benzinga
Nasdaq Edges Higher; AngioDynamics Shares Plummet
U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday. 
Via Benzinga
AngioDynamics, Resources Connection And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded mixed, with the Dow Jones dropping more than 85 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
AngioDynamics Reports Fiscal 2023 First Quarter Financial Results; Reaffirms Guidance
From AngioDynamics, Inc.
Via Business Wire
Earnings Scheduled For October 6, 2022
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.52 per share on revenue of $2.85 billion. 
Via Benzinga
AngioDynamics's Earnings: A Preview
AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Thursday, 2022-10-06. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics... 
Via Benzinga
AngioDynamics to Report Fiscal 2023 First Quarter Financial Results on October 6, 2022
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Present at the Canaccord Genuity Growth Conference
From AngioDynamics, Inc.
Via Business Wire
Cboe's Weekly Market Recap: July 5th to July 8th
Following weeks of consistent bearish action, the markets took a slight breather last week.  
Via Benzinga
Recap: AngioDynamics Q4 Earnings
  AngioDynamics (NASDAQ:ANGO) reported its Q4 earnings results on Tuesday, July 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings AngioDynamics reported in-line... 
Via Benzinga
AngioDynamics Reports Fiscal Year 2022 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2023 Guidance
From AngioDynamics, Inc.
Via Business Wire
U.S. Stock Futures Down Ahead Of PepsiCo Earnings
Pre-open movers 
Via Benzinga
Earnings Scheduled For July 12, 2022
Companies Reporting Before The Bell • AngioDynamics (NASDAQ:ANGO) is estimated to report quarterly earnings at $0.01 per share on revenue of $83.25 million. 
Via Benzinga
PepsiCo, GameStop And 3 Stocks To Watch Heading Into Tuesday
With the US stock futures trading lower this morning on Tuesday after the Nasdaq recorded sharp losses in the previous session, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Earnings Preview: AngioDynamics
AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Tuesday, 2022-07-12. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics... 
Via Benzinga
AngioDynamics to Report Fiscal 2022 Fourth Quarter and Full-Year Financial Results on July 12, 2022
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Present at the UBS Global Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Present at the BofA Securities Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.